Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexaria Bioscience Corp

1.00
+0.02352.41%
Volume:26.07K
Turnover:25.73K
Market Cap:19.48M
PE:-1.70
High:1.02
Open:0.9700
Low:0.9500
Close:0.9765
Loading ...
Jun 08, 2024

Correspondence

Form CORRESP - Correspondence
Jun 03, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Apr 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Correspondence

Form CORRESP - Correspondence
Mar 15, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Major Issues Report

Form 8-K - Current report
Jan 19, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Correspondence

Form CORRESP - Correspondence
Nov 30, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 21, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]